Preparation and evaluation of novel directly-compressed fast-disintegrating furosemide tablets with sucrose stearic acid ester

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 6, 2009, Pages 1126-1130

  Koseki, Takuma ^a   Onishi, Hiraku ^a   Takahashi, Yuri ^a   Uchida, Minoru ^b   Machida, Yoshiharu ^a  

^a HOSHI UNIVERSITY   (Japan)

^b MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

Fast disintegrating tablet; Furosemide; Plasma concentration; Sucrose stearic acid ester; Tablet property

Indexed keywords

ALCOHOL; CELLULOSE; CROSCARMELLOSE SODIUM; FUROSEMIDE; STEARIC ACID DERIVATIVE; SUCROSE STARIC ACID ESTER; UNCLASSIFIED DRUG; XYLITOL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG SOLUBILITY; DRUG SYNTHESIS; EVAPORATION; HYDROPHILICITY; LIPOPHILICITY; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; POWDER; RAT; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET HARDNESS; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; DRUG COMPOUNDING; ESTERS; EXCIPIENTS; FUROSEMIDE; MALE; MICROSCOPY, ELECTRON, SCANNING; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; SUCROSE; SURFACE PROPERTIES; TABLETS; TIME FACTORS;

EID: 66549086278     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1126     Document Type: Article

References (33)

1. Honda Y., Nakano M., Jpn. J. Hosp. Pharm., 24, 533-540 (1998).
2. Mizumoto T., Masuda Y., Yamamoto T., Yonemochi E., Terada K., Int. J. Pharm., 306, 83-90 (2005).
3. Watanabe A., Hanawa T., Sugihara M., Yakuzaigaku, 54, 77-87 (1994).
4. Hanawa T., Watanabe A., Tsuchiya T., Ikoma R., Hidaka M., Sugihara M., Chem. Pharm. Bull., 43, 284-288 (1995).
5. Fukami J., Yonemochi E., Yoshihashi Y., Terada K., Int. J. Pharm., 310, 101-109 (2006).
6. Baldi F., Malfertheiner P., Digestion, 67, 1-5 (2003).
7. Loder E. W., Dowson A. J., Spierings E. L., Curr. Med. Res. Opin., 21 (Suppl. 3), S8-S12 (2005).
8. Moen M. D., Keating G. M., Drugs, 66, 883-890 (2006).
9. Seager H., J. Pharm. Pharmacol., 50, 375-382 (1998).
10. Corveleyn S., Remon J. P., Drug Dev. Ind. Pharm., 25, 1005-1013 (1999).
11. Fu Y., Yang S., Jeong S. H., Kimura S., Park K., Crit. Rev. Ther. Drug Carrier Syst., 21, 433-476 (2004).
12. Rawas-Qalaji M. M., Simons F. E., Simons K. J., AAPS PharmSciTech., 7, E1-E7 (2006).
13. Watanabe Y., Koizumi K., Zama Y., Kiriyama M., Matsumoto Y., Matsumoto M., Biol. Pharm. Bull., 18, 1308-1310 (1995).
14. Jin Y., Ohkuma H., Wang H., Natsume H., Sugibayashi K., Morimoto Y., Yakugaku Zasshi, 122, 989-994 (2002).
15. Fukami J., Ozawa A., Yoshihashi Y., Yonemochi E., Terada K., Chem. Pharm. Bull., 53, 1536-1539 (2005).
16. Koseki T., Onishi H., Takahashi Y., Uchida M., Machida Y., Chem. Pharm. Bull., 56, 1384-1388 (2008).
17. Waller E. S., Crismon M. L., Smith R. V., Bauza M. T., Doluisio J. T., Biopharm. Drug Dispos., 9, 211-218 (1988).
18. Yagi N., Kiuchi T., Satoh H., Terashima Y., Kenmotsu H., Sekikawa H., Takada M., Biol. Pharm. Bull., 9, 616-622 (1996).
19. Tsai T., Wu J. S., Ho H. O., Sheu M. T., J. Pharm. Sci., 87, 117-122 (1998).
20. Siaan M., Pintye-Hódi K., Szabó-Révész P., Kása P. Jr., Erõs I., Drug Dev. Ind. Pharm., 26, 1013-1018 (2000).
21. Chen C. R., Cho S. L., Lin C. K., Lin Y. H., Chiang S. T., Wu H. L., Chem. Pharm. Bull., 46, 478-481 (1998).
22. Sallam E., Ibrahim H., Dahab R. A., Shubair M., Khalil E., Drug Dev. Ind. Pharm., 24, 501-507 (1998).
23. Suzuki H., Onishi H., Hisamatsu S., Masuda K., Takahashi Y., Iwata M., Machida Y., Int. J. Pharm., 278, 51-61 (2004).
24. Mäkinen K. K., Saag M., Isotupa K. P., Olak J., Nõmmela R., Söderling E., Mäkinen P. L., Caries Res., 39, 207-215 (2005).
25. Aoshima H., Miyagisnima A., Nozawa Y., Sadzuka Y., Sonobe T., Int. J. Pharm., 293, 25-34 (2005).
26. Terashi M., J. Kagoshima City Med. Assoc., 43, 20 (2004).
27. Meyer B. H., Müller F. O., Hundt H. K., Grigoleit H. G., Hajdu P., Heptner W., S. Afr. Med. J., 59, 891-893 (1981).
28. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T., J. Pharmacobiodyn., 4, 879-885 (1981).
29. Ogata K., Takamura N., Kashiwagi S., Hamada R., Kodama H., Arimori K., Jpn. J. Pharm. Health Care Sci., 27, 553-558 (2001).
30. Gavrilov A. S., Gusel'nikova E. V., Ptrov A. V., Pharmaceut. Chem. J., 38, 41-44 (2004).
31. Säkkinen M., Tuononen T., Jürjenson H., Veski P., Marvola M., Eur. J. Pharm. Sci., 19, 345-353 (2003).
32. Nihon Generic Co., Ltd., "Interview Form: Furosemide Tablets 20 mg JG," 2007, p. 9.
33. Kyorin Rimedio Co., Ltd., "Interview Form: Furosemide Tablets 40 mg Mita," 2008, p. 14.